Enabling confident differential diagnostics in dementia
cNeuro is Combinostics’ cloud platform for quantitative assessment of brain images and for providing clinical decision support in neurological disorders.
Combinostics offers two modules in the cNeuro product family, cMRI and cDSI.
Quantify volumes of 133 brain regions, vascular burden, medial temporal lobe atrophy (MTA) score, global cortical atrophy (GCA) scale and Fazekas scale.
Compare measures to reference data.
Review results interactively in a web viewer using a standard web browser and obtain a report.
Compare neuropsychology, MRI, CSF and genetics measured from your patient to data of previously diagnosed cases.
Quantify the patient’s similarity relative to etiology (AD, FTLD, VaD and cognitive normal) and progression (stable and progressive MCI).
Visualize data in an intuitive way with our patented disease state fingerprint (DSI) technology.
Tampere January 15, 2018 – The digital health company Combinostics received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its image quantification software cNeuro cMRI. The software enables clinicians to get objective measurements of atrophy in...read more
Combinostics will have a booth at RSNA 2017 from November 26 to December 1. Please come and visit us! We can be found within the new Machine Learning Showcase exhibition: North - Hall B:...read more
Out of 134 participants, Combinostics was awarded the second place at the Future X Healthcare event organized by Roche in Munich November 9, 2017. The event was a day full of inspiration with top speakers, start-up pitches, a networking innovation fair, awards and a...read more